Frequencies for first 10,000 rows of drug5cl1 variable in nhamcsed2005 dataset : ndc code #1 for medication #5 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, local (injectable) | 5 0.05 0.05 adjuncts to anesthesia/analeptics | 6 0.06 0.11 antidotes, specific | 3 0.03 0.14 antimicrobial agents, unspecified | 2 0.02 0.16 penicillins | 10 0.10 0.26 cephalosporins | 16 0.16 0.42 erythromycins/lincosamides/macrolides | 8 0.08 0.50 tetracyclines | 4 0.04 0.54 aminoglycosides | 1 0.01 0.55 sulfonamides and trimethoprim | 4 0.04 0.59 urinary tract antiseptics | 1 0.01 0.60 miscellaneous antibacterial agents | 8 0.08 0.68 quinolones/derivatives | 16 0.16 0.84 antifungals | 1 0.01 0.85 antiviral agents | 2 0.02 0.87 deficiency anemias | 4 0.04 0.91 anticoagulants/thrombolytics | 20 0.20 1.11 cardiac glycosides | 1 0.01 1.12 antiarrhythmic agents | 1 0.01 1.13 antianginal agents | 15 0.15 1.28 agents used to treat shock/hypotension | 2 0.02 1.30 antihypertensive agents | 6 0.06 1.36 diuretics | 11 0.11 1.47 coronary vasodilators | 3 0.03 1.50 relaxants/stimulants, urinary tract | 1 0.01 1.51 calcium channel blockers | 8 0.08 1.59 beta blockers | 10 0.10 1.69 alpha agonist/alpha blockers | 3 0.03 1.72 ace inhibitors | 9 0.09 1.81 sedatives and hypnotics | 31 0.31 2.12 antianxiety agents | 18 0.18 2.30 antipsychotic/antimanics | 8 0.08 2.38 antidepressants | 8 0.08 2.46 alzheimer-type dementia | 1 0.01 2.47 antiemetics | 9 0.09 2.56 disorders, acid/peptic | 30 0.30 2.86 antidiarrheals | 3 0.03 2.89 laxatives | 3 0.03 2.92 miscellaneous gastrointestinals | 3 0.03 2.95 antispasmodics/anticholinergics | 2 0.02 2.97 antacids | 3 0.03 3.00 metabolic and nurtient agents, unspec.. | 1 0.01 3.01 hyperlipidemia | 9 0.09 3.10 vitamins/minerals | 13 0.13 3.23 nutrition, enteral/parenteral | 1 0.01 3.24 repl/regs of electrolytes/water balance | 39 0.39 3.63 calcium metabolism | 3 0.03 3.66 hematopoietic growth factor | 1 0.01 3.67 adrenal corticosteroids | 17 0.17 3.84 blood glucose regulators | 17 0.17 4.01 thyroid/antithyroid | 3 0.03 4.04 relaxants/stimulants, uterine | 1 0.01 4.05 contraceptives | 1 0.01 4.06 vaccines/antisera | 2 0.02 4.08 dermatologics, misc. | 3 0.03 4.11 topical steroids | 1 0.01 4.12 topical anti-infectives | 3 0.03 4.15 extrapyramidal movement disorders | 2 0.02 4.17 skeletal muscle hyperactivity | 13 0.13 4.30 anticonvulsants | 7 0.07 4.37 antineoplastics, miscellaneous | 1 0.01 4.38 glaucoma | 1 0.01 4.39 ocular anti-infective/anti-inflammatory | 1 0.01 4.40 vertigo/motion sickness/vomiting | 14 0.14 4.54 analgesics/general | 3 0.03 4.57 analgesics, narcotic | 94 0.94 5.51 analgesics, non-narcotic | 36 0.36 5.87 antiarthritics | 3 0.03 5.90 antigout | 1 0.01 5.91 nsaid | 50 0.50 6.41 antiprotozoals | 5 0.05 6.46 antimalarials | 1 0.01 6.47 antiasthmatics/bronchodilators | 32 0.32 6.79 nasal decongestants | 1 0.01 6.80 antitussives/expectorants/mucolytics | 5 0.05 6.85 antihistamines | 12 0.12 6.97 corticosteroid-inhalation/nasal | 1 0.01 6.98 unclassified | 7 0.07 7.05 pharmaceutical aids | 1 0.01 7.06 homeopathic products | 1 0.01 7.07 . | 9,293 92.93 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016